Your browser doesn't support javascript.
loading
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
Wang, Victoria E; Blaser, Bradley W; Patel, Ravi K; Behbehani, Gregory K; Rao, Arjun A; Durbin-Johnson, Blythe; Jiang, Tommy; Logan, Aaron C; Settles, Matthew; Mannis, Gabriel N; Olin, Rebecca; Damon, Lloyd E; Martin, Thomas G; Sayre, Peter H; Gaensler, Karin M; McMahon, Emma; Flanders, Michael; Weinberg, Vivian; Ye, Chun J; Carbone, David P; Munster, Pamela N; Fragiadakis, Gabriela K; McCormick, Frank; Andreadis, Charalambos.
Afiliação
  • Wang VE; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Blaser BW; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Patel RK; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Behbehani GK; CoLabs, University of California, San Francisco, San Francisco, Califoria.
  • Rao AA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Durbin-Johnson B; CoLabs, University of California, San Francisco, San Francisco, Califoria.
  • Jiang T; Bioinformatics Core, Genome Center, University of California, Davis, Davis, California.
  • Logan AC; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Settles M; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Mannis GN; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Olin R; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Damon LE; Bioinformatics Core, Genome Center, University of California, Davis, Davis, California.
  • Martin TG; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Sayre PH; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Gaensler KM; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • McMahon E; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Flanders M; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Weinberg V; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Ye CJ; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Carbone DP; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • Munster PN; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Fragiadakis GK; Department of Medicine, University of California, San Francisco, San Francisco, California.
  • McCormick F; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Andreadis C; Department of Medicine, University of California, San Francisco, San Francisco, California.
Blood Cancer Discov ; 2(5): 434-449, 2021 09.
Article em En | MEDLINE | ID: mdl-34514432
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteômica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteômica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2021 Tipo de documento: Article